- 2020-present: Member of the Scientific Advisory Board of Science Translational Medicine.
- 2020-present: Member of the Scientific Editorial Board of Frontiers in Genome Editing (https://www.frontiersin.org/journals/genome-editing/editors).
- 2019-present: Member of the Scientific Editorial Board of Experimental Biology and Medicine (http://www.ebm.sagepub.com).
- 2023-present: Member of the College of Reviewers for the ERC-Portugal pre-assessment programme. Foundation for Science and Technology, Portugal.
- 2022-present: Scientific founder of the CNR-OSR Spin-off “REPRON Therapeutics”
- 2022-present: Member of the HCERES Committees for the evaluation of the Neuroscience Institutes of CNRS and INSERM INCI, INP and INMED in France
- 2023-2020: Deputy chair and member Scientific Committee for evaluation of the Academy of Finland grants, Program of Neuroscience
- 2023: Abstract Review Chair for Neurological Disease of the American Society of Gene and Cell Therapy Meeting (LA, USA) 
- 2023: Chair of the Scientific Committee on cell therapy/iPS cells/organoids of the European Society for Gene and Cell Therapy (ESGCT)
- 2022: Member Scientific Advisory Board of I-STEM (AFM-Telethon Institute), Evry-Paris.
- 2020-2018: Member of the Reviewer Scientific Panel of the California Institute of Regenerative Medicine (CIRM) USA.
- 2019-2015: Member of the evaluating committee for the Consolidator European Research Council (CoERC) grants, Panel LS7.
- 2018-2015: Member of the Armenise Foundation’s Italian Scholarship Advisory Committee-Armenise Harvard Foundation.

REPRON Therapeutics – Scientific Founder (www.reprontherapeutics.com)
2022-2025 Ministry of Health PNRR M6/C2 call: “Implementing a national biobank of genetic, sporadic and prodromic Parkinson's disease with whole genome analysis and functional assessment of polygenic inheritance by iPSC technology”
2023-2024 EXTEND – National technology transfer Biotech Hub: “Cell-type regulated (CTRG)-MECP2 gene therapy for the treatment of Rett syndrome“
2022-2025 HORIZON-EU-EIC-PathfinderOpen: “DBR-4-Deep Brain Reconstruction”
2022-2024 GoFar Italian Association for Friedreich’s Ataxia: “Comparative analysis of FA patient iPSC-derived retinal, sensory and cortical neurons and reactivation of the silenced Frataxin gene with an epigenetic approach.
2022-2024 Telethon-Cariplo Alliance grant (GJC21065): “Dissecting the pathomolecular mechanisms of Prr12 gene inactivation leading to neurodevelopmental and eye abnormalities&rdquo.
2022-2025 Private donation. Project: “Unveiling the molecular basis of visual loss and neurological alterations in Wolfram syndrome patient-derived cells and mutant mice&rdquo.;
2022-2025 Ministry of University (MUR), PRIN2020: “Selective expression of a SOX2 epigenetic silencer by in situ viral delivery for the treatment of glioblastoma multiforme&rdquo.
2021-2024 EU-E-RARE: “Therapeutic strategies for Dravet syndrome: upregulation of endogenous SCN1A and modulation of pathological remodeling” 
2014-2019 Advanced Grant European Research Council (adERC): “New experimental therapeutic approaches for Parkinson’s disease by direct DA neuronal reprogramming”

2018-present Director of Research, Institute of Neuroscience, CNR, Milan, Italy
2015-2017 Senior scientist, Institute of Neuroscience, CNR, Milan, Italy
2011-present Head of Unit, Division of Neuroscience, IRCCS Ospedale San Raffaele, Milan, Italy
2002-2010 Group leader, Stem Cell Institute (SCRI), IRCCS Ospedale San Raffaele, Milan, Italy
2003 Guest scientist, UCSF San Francisco, Lab. Developmental Neurobiology. Host: Prof. J. Rubinstein
2001 Staff scientist, Telethon Institute of Genetics and Medicine (TIGEM), Milan, Italy
1998-2000 Postdoc fellow, Neurogenetics Dept., Helmholtz Centre, Munich, Germany
1994-1997 PhD student, Mentor: Prof. E. Boncinelli, IRCCS Ospedale San Raffaele